March 2026 — Q2 Pipeline Forecast
Federal health IT opportunities expected to drop April–June 2026, ranked by confidence, with action windows and competitive dynamics for each.
Bottom line up front
Q2 FY2026 lands inside the OMB passback window and the FY2027 budget submission cycle, so the volume of new solicitations will look modest while the strategic weight of each one is higher than a typical quarter. I'm tracking 12 high-confidence opportunities, 9 medium-confidence, and a rolling backlog from Q1 that is shifting into this window after the DOGE-driven task-order slowdown. The single most important call for BD teams: DHA Health IT Deployment Support Services (HITDSS), VA OIT ECMS Wave 3 task orders, and ARPA-H ADVOCATE Phase 1A awards are the three releases most likely to reshape the competitive landscape this quarter.
Pipeline at a glance
Top 5 opportunities to work now
The follow-on to the DHITUC vehicle. Draft RFP expected May; final RFP June. Covers clinical system deployment, integration, and sustainment support across MHS GENESIS, My Military Health, and cross-domain data services. DHA is signaling a move toward more performance-based scopes and fewer SME labor categories — a direct response to DOGE pressure on advisory spend. Small business share is being expanded: expect a multi-tier award structure with dedicated SDVOSB and 8(a) tracks alongside full-and-open.
- Ceiling
- ~$2.4B over 5 years
- NAICS
- 541512 primary; 541511 secondary
- Set-aside
- Multi-tier (SDVOSB + 8(a) + F&O)
- Action window
- Teaming decisions locked by early May
Wave 3 call orders against the ECMS parent IDIQ are the delayed Q1 releases coming into Q2. Focus areas: Veteran-facing digital services, claims modernization, and VA-DOD interoperability. VA OIT has been explicit that Wave 3 task orders will emphasize measurable user-facing outcomes over staff augmentation. Incumbents who can document throughput, error-rate reduction, or claim processing time improvements enter with a decisive advantage.
- Ceiling (aggregate)
- ~$850M across expected call orders
- NAICS
- 541512
- Set-aside
- Limited to ECMS primes
- Action window
- Proposal responses tight — 21-day average
Not a new solicitation — the Q2 event is the award announcements for the ADVOCATE agentic AI cardiovascular care program. Full proposals closed April 1; awards are tracked to Q3 FY2026 but ARPA-H has been releasing decisions ahead of schedule on recent programs. These will be the first federal awards to explicitly fund agentic AI in clinical settings with FDA engagement built into the program structure. The winners become the reference dataset for every clinical AI solicitation that follows.
- Instrument
- Other Transaction Agreements
- Expected awardees
- 4–7 performer teams
- Period
- 39 months base, Phase 1A
- Watch for
- Teaming signals — non-award teams will seek subcontract paths
With FY2026 CDMRP funding restored to $1.27B, the program announcements (PAs) for individual research programs post on the usual rolling Q2 cadence. Priority programs to monitor: Traumatic Brain Injury and PTSD Research Program, Prostate Cancer Research Program, and Joint Warfighter Medical Research Program. For firms with clinical research delivery capability and past CDMRP performance, this is the cleanest growth lane in the stack — advisory-heavy competitors are retreating as DOGE pressure compresses their core.
- Instrument
- Mix of grants + cooperative agreements
- Total FY2026
- $1.27B restored
- Relevant NAICS
- 541712 (R&D in physical/engineering) and 541715
- Action window
- PAs post rolling — monitor weekly
HTI-5 proposed rule closed its comment period in February. If ONC finalizes within Q2 (60% probability), implementation support contracts for AI-enabled clinical decision support certification and TEFCA exchange operations follow in 45–90 days. The political risk is real — administration deregulation posture may delay finalization into Q3. Firms should complete teaming and white paper positioning now so they can respond inside 30 days if the final rule drops.
- Expected ceiling
- $180M–$250M (implementation support)
- NAICS
- 541512; 541990 secondary
- Set-aside
- TBD — watch for small business preference in final rule
- Risk factor
- Timing tied to HTI-5 final rule
Next 7 high-confidence opportunities
- DHA MHS GENESIS Enterprise Support Sustainment — bridge task order expected May while the long-term vehicle is shaped. $180M–$240M one-year bridge ceiling.
- VA EHRM Technical Integration Office support recompete — draft RFP already in circulation; final RFP mid-Q2. Incumbent positioned strong, but VA has signaled openness to restructured teaming.
- IHS Electronic Health Record Modernization task orders — Q2 should see the first post-pilot operational task orders against the IHS EHR Modernization IDIQ.
- DHA J6 Zero Trust Architecture implementation — follow-on to the ZTA pilot. Cybersecurity compliance core, not advisory — one of the least DOGE-exposed scopes in the quarter.
- HHS AI Office governance and evaluation support — new AI governance funding line being stood up. Small initial ceiling ($25M–$40M) but strategic foothold for firms building federal AI compliance practices.
- VA Community Care Network telehealth sustainment — CCN telehealth operations contract supporting 9M+ enrolled Veterans. Stable demand, low DOGE exposure.
- DHA Virtual First / My Military Health expansion task orders — post-Amwell rollout expansion. Incumbents (LPDH and partners) carry structural advantage; open for mid-tier teaming.
Competitive dynamics for the quarter
The Q2 competitive field is shaped by three dynamics working in parallel. First, advisory-heavy primes are under pressure to redirect capacity toward delivery-centric scopes — expect aggressive teaming outreach from firms trying to reposition books. Second, mid-tier integrators with clinical delivery past performance and ATO currency are the single most leverage-able teaming partner in the stack; their capacity is the constraint. Third, small business primes in the 8(a), SDVOSB, and WOSB tracks have a genuinely improved competitive position this quarter as agencies expand set-aside share to satisfy small business goals under tighter overall obligation ceilings.
For capture managers: the signal to prioritize is whether your past performance can be rewritten to lead with measurable outcomes (visits delivered, time reduced, errors caught, claims processed) rather than staff deployed or strategic advice. Evaluators in Q2 will reward the former and penalize the latter more than in any quarter in the last three years.
What to do this month
- Lock HITDSS teaming by early May. Draft RFP release will compress the window and the primes currently shaping the solution are already circulating teaming papers.
- Audit your past performance narratives. For every relevant PP volume, verify that the opening paragraph leads with a quantified outcome, not an activity. Our ProposalPulse red-team pass catches the difference.
- Monitor ARPA-H ADVOCATE awards weekly. Non-winning teams will be looking for subcontract positioning within 30 days of announcement. Prepare a 3-paragraph capability brief you can send within 48 hours.
- Revisit your FY2027 pipeline the week after OMB passback. This is the single most information-dense week of the quarter for pipeline revision.
- Stress-test cash flow against a 60-day task order lag. The DOGE-driven slowdown from Q1 is still propagating — don't assume it resolves automatically in Q2.
Sources and methodology
Pipeline confidence is Mission Meets Tech analysis based on: SAM.gov Contract Opportunities posting patterns and agency-specific pre-solicitation signals; USASpending.gov historical task order release cadences against parent IDVs; Congress.gov committee report language for FY2026 appropriations; agency acquisition forecasts; and direct conversations with program office representatives at DHA, VA OIT, and HHS (not attributed per ground rules). Opportunity ceilings are estimated from comparable historical awards and agency budget justification documents. This brief represents Mission Meets Tech analysis for MMT Premium subscribers; verify each claim against primary sources before committing bid & proposal resources.